In this episode of The Investor Relations Podcast, Michael Loftus, Biotech Growth Architect and Family Office Strategist, breaks down how investor relations strategies must adapt across the different stages of a biotech company’s growth. Drawing on his experience in capital markets and life sciences, Michael explains how IR leaders and executives can communicate more effectively with investors depending on whether their company is early-stage, mid-stage, or preparing for commercialization.
The conversation highlights why investors often place their confidence in the team during early-stage development, how mid-stage companies should emphasize asset value and visibility through investor conferences, and what late-stage biotechs must do to showcase the real-world impact of their products. For biotech executives, IR professionals, and capital markets stakeholders, this episode offers a practical roadmap for aligning investor communications with company maturity.
#InvestorRelations #Biotech #LifeSciences #CapitalMarkets #BiotechInvesting #ShareholderEngagement
Connect with the Guest
Company: https://www.poccap.com
LinkedIn: https://www.linkedin.com/in/mikeloftusclinicaltrials/
Podcast profile: View all of their episodes here
Connect with the Host
Joshua Wilson LinkedIn: https://www.linkedin.com/in/joshuabrucewilson/
The Investor Relations Podcast YouTube channel: https://www.youtube.com/@TheInvestorRelationsPodcast
Contact Link
https://www.theinvestorrelationspodcast.com/contact/
Disclaimer: Joshua Wilson is a licensed Florida real estate broker and holds FINRA Series 79 and Series 63 licensure. The content of this podcast is for informational and educational purposes only and should not be considered legal, financial, or compliance advice. All views and opinions expressed by the host and guests are their own and do not necessarily reflect the policies or positions of any regulatory agency, organization, or employer. Listeners should consult their own legal counsel, compliance teams, or financial advisors to ensure adherence to applicable regulations, including SEC, FINRA, and other industry-specific requirements. This podcast does not constitute a solicitation or recommendation for any financial products or services.
Let’s Connect on LinkedIn:
https://www.linkedin.com/in/joshuabrucewilson/
To Contact Us, Please Visit:
